23 April 2021>: Original Paper
A Single-Center Experience with Lung Transplants During the COVID-19 Pandemic
Wojtek Karolak 1ABE , Elżbieta Woźniak-Grygiel 2CE , Monika Łącka 3BC , Jacek Wojarski 1BG , Salma Ali Addo 4EF , Adith Kumaravel 4EF , Salin Khan 4EF , Reema Shinde 4EF , Ikram Mukhtar Nuur 4EF , Feven Kifle Reta 4EF , Jan Rogowski 1G , Ewa Jassem 4EG , Krystyna Pastwa 1F , Aleksandra Pałasz 1B , Nikodem Ulatowski 1B , Sławomir Żegleń 24ADG*DOI: 10.12659/AOT.929946
Ann Transplant 2021; 26:e929946
Table 1 Characteristics of patients considered for lung transplantation.
Characteristics | Qualifications for lung transplant 2019 before COVID-19N=102Mean±SD/n (%) | Qualifications for lung transplant 2020 (till November) during COVID-19N=87Mean±SD/n (%) | p |
---|---|---|---|
56.0±10.8 | 57.9±8.5 | 0.1792 | |
Female | 28 (27.5%) | 34 (39.1%) | 0.0905 |
Male | 74 (72.5%) | 53 (60.9%) | 0.0905 |
COPD | 44 (43.1%) | 31 (35.6%) | 0.2934 |
IPF | 9 (8.8%) | 12 (13.9%) | 0.2668 |
IPAH | 8 (7.8%) | 3 (3.5%) | 0.2082 |
EAA | 16 (15.7%) | 16 (18.4%) | 0.6219 |
UIP | 16 (15.7%) | 19 (21.8%) | 0.2818 |
CPFE | 6 (4.9%) | 1 (1.1%) | 0.1361 |
COPD+UIP | 2 (2.0%) | 3 (3.5%) | 0.5253 |
EMPHYSEMA | 2 (2.0%) | 1 (1.1%) | 0.6215 |
LAM | 0 (0.0%) | 1 (1.1%) | 0.2883 |
COVID-19 – corona virus disease – 2019; COPD – chronic obstructive pulmonary disease; CF – cystic fibrosis; IPF – idiopathic pulmonary fibrosis; IPAH – idiopathic pulmonary arterial hypertension; EAA – extrinsic allergic alveolitis; UIP – usual interstitial pneumonia; LAM – lymphangioleiomyomatosis; CPFE – combined pulmonary fibrosis and emphysema; SD – standard deviation. |